The demand for Lipid-Lowering Agents in Southern Asia has been increasing steadily in recent years due to a combination of factors.
Customer preferences: Customers in Southern Asia are increasingly concerned about their health and are seeking ways to prevent chronic diseases such as cardiovascular disease. As a result, there has been a growing demand for Lipid-Lowering Agents, which are used to lower cholesterol levels and reduce the risk of heart disease.
Trends in the market: One of the key trends in the Lipid-Lowering Agents market in Southern Asia is the increasing popularity of generic drugs. Generic Lipid-Lowering Agents are becoming more widely available and are often significantly cheaper than their branded counterparts. This has led to increased competition in the market, which has helped to drive down prices and make these drugs more accessible to a wider range of customers.Another trend in the market is the increasing use of combination therapies. Many Lipid-Lowering Agents are now available in combination with other drugs, such as blood pressure medications. This has made it easier for patients to manage multiple conditions simultaneously, which has been particularly beneficial for older patients who may have multiple health issues.
Local special circumstances: In some countries in Southern Asia, there are specific local factors that are driving demand for Lipid-Lowering Agents. For example, in India, there is a high prevalence of diabetes, which is a major risk factor for cardiovascular disease. As a result, there is a growing demand for Lipid-Lowering Agents to help manage this risk.
Underlying macroeconomic factors: The Lipid-Lowering Agents market in Southern Asia is also influenced by broader macroeconomic factors. For example, many countries in the region are experiencing rapid economic growth, which has led to an increase in disposable income. This has made healthcare more affordable for many people, which has in turn increased demand for Lipid-Lowering Agents.In conclusion, the Lipid-Lowering Agents market in Southern Asia is growing due to a combination of factors, including increasing customer awareness of the importance of managing cholesterol levels, the availability of generic drugs and combination therapies, local factors such as the high prevalence of diabetes in some countries, and broader macroeconomic factors such as increasing disposable income.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
